"Ophthalmic Solutions" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Sterile solutions that are intended for instillation into the eye. It does not include solutions for cleaning eyeglasses or CONTACT LENS SOLUTIONS.
Descriptor ID |
D009883
|
MeSH Number(s) |
D26.776.708.645 D27.505.954.578.645 D27.720.752.608
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Ophthalmic Solutions".
Below are MeSH descriptors whose meaning is more specific than "Ophthalmic Solutions".
This graph shows the total number of publications written about "Ophthalmic Solutions" by people in this website by year, and whether "Ophthalmic Solutions" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2001 | 0 | 1 | 1 |
2002 | 0 | 1 | 1 |
2003 | 1 | 1 | 2 |
2004 | 0 | 1 | 1 |
2006 | 0 | 1 | 1 |
2007 | 0 | 1 | 1 |
2012 | 0 | 2 | 2 |
2018 | 1 | 0 | 1 |
2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ophthalmic Solutions" by people in Profiles.
-
Tanaka AC, Robbins CC, Wiss K, Chen VM. Frequent corneal abrasions precede scarring and vision loss in epidermolysis bullosa: An international patient survey. J Am Acad Dermatol. 2020 Sep; 83(3):917-919.
-
Shivanna M, Anand M, Chakrabarti S, Khanna H. Ocular Ciliopathies: Genetic and Mechanistic Insights into Developing Therapies. Curr Med Chem. 2019; 26(17):3120-3131.
-
Marshall LL, Hayslett RL, Stevens GA. Therapy for Open-Angle Glaucoma. Consult Pharm. 2018 Aug 01; 33(8):432-445.
-
Huang JF, Yafawi R, Zhang M, McDowell M, Rittenhouse KD, Sace F, Liew SH, Cooper SR, Pickering EH. Immunomodulatory effect of the topical ophthalmic Janus kinase inhibitor tofacitinib (CP-690,550) in patients with dry eye disease. Ophthalmology. 2012 Jul; 119(7):e43-50.
-
Rifkin L, Schaal S. Shortening ocular pain duration following intravitreal injections. Eur J Ophthalmol. 2012 Nov-Dec; 22(6):1008-12.
-
Boyer DS, Beer PM, Joffe L, Koester JM, Marx JL, Weisberger A, Yoser SL. Effect of adjunctive diclofenac with verteporfin therapy to treat choroidal neovascularization due to age-related macular degeneration: phase II study. Retina. 2007 Jul-Aug; 27(6):693-700.
-
Dirks MS, Noecker RJ, Earl M, Roh S, Silverstein SM, Williams RD. A 3-month clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with normal-tension glaucoma. Adv Ther. 2006 May-Jun; 23(3):385-94.
-
Koevary SB, Lam V, Patsiopoulos G. Pharmacokinetics of insulin uptake by ocular tissues and the role of cerebrospinal fluid in optic nerve insulin accumulation following topical insulin application. Optometry. 2004 Mar; 75(3):183-8.
-
Koevary SB. Pharmacokinetics of topical ocular drug delivery: potential uses for the treatment of diseases of the posterior segment and beyond. Curr Drug Metab. 2003 Jun; 4(3):213-22.
-
Patsiopoulos G, Lam V, Lake S, Koevary SB. Insulin and tropicamide accumulate in the contralateral, untreated eye of rats following ipsilateral topical administration by a mechanism that does not involve systemic uptake. Optometry. 2003 Apr; 74(4):226-32.